Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Kezar Life Sciences
Company

Kezar Life Sciences

Tracked across 1 events · 29 articles · First seen Mar 30, 2026 · Last active Apr 16, 2026

Sentiment
-10
Attention
0
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
0 -10
Business
Monteverde & Associates PC Investigates Multiple M&A Deals
Kezar Life Sciences is being investigated by Monteverde & Associates PC regarding its sale to Aurinia Pharmaceuticals Inc., with shareholders expected to receive $6.955 per share in cash and one non-transferable contingent value right.
Mar 30, 2026 · 29 articles
Key Actions (2)
80 Monteverde & Associates PC launched investigation into proposed transactions Kezar Life SciencesMonteverde & Associates PC...
70 Kezar Life Sciences sold to Aurinia PharmaceuticalsMonteverde & Associates PC...
NEWSDESK
Track Kezar Life Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.